Company intelligence / Profile preview

Mospharm

Bogorodskoye, Moscow Oblast, Russia

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Mospharm is a Russian pharmaceutical company specializing in the full-cycle manufacturing of infusion and injection solutions. Founded in 2005 and based in the Moscow region, the company operates a modern production facility designed and built from the ground up in compliance with GMP standards. Mospharm's product portfolio includes a wide range of essential medical solutions, such as sodium chloride, glucose, paracetamol, levofloxacin, and specialized kits like Normacor for cardioplegia. The company serves as a key supplier of vital infusion therapies to hospitals, clinics, and inpatient facilities across Russia.

Therapeutic areas: Infectious DiseasesNeurologyCardiovascularNephrologyMetabolic Disorders
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Mospharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mospharm.

Explore the full profile